SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer shines on receiving approval to sell Pfizer Animal Pharma

09 Nov 2012 Evaluate

Pfizer is currently trading at Rs. 1153.00, up by 18.90 points or 1.67% from its previous closing of Rs. 1134.10 on the BSE.

The scrip opened at Rs. 1145.00 and has touched a high and low of Rs. 1162.95 and Rs. 1145.00 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1410.00 on 23-Apr-2012 and a 52 week low of Rs. 1071.55 on 30-Dec-2011.

Last one week high and low of the scrip stood at Rs. 1165.00 and Rs. 1130.00 respectively. The current market cap of the company is Rs. 3,440.00 crore.

The promoters holding in the company stood at 70.75% while Institutions and Non-Institutions held 9.44% and 19.81% respectively.

Pfizer has received an approval for the sale of its wholly owned subsidiary Pfizer Animal Pharma to Pfizer Animal Health India, a 100% indirect subsidiary of Pfizer Inc., USA for a consideration of Rs 471.60 crore.

The board at its meeting held on November 08, 2012 has approved for the same. Further, the above is however subject to receipt of prior regulatory approvals.

Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.

Pfizer Share Price

4794.05 -17.00 (-0.35%)
11-May-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.45
Dr. Reddys Lab 1275.00
Cipla 1333.20
Zydus Lifesciences 932.75
Lupin 2237.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×